my question with ecofibre's listing is market timing, given the volatility in the market presently, & not just the market in general but also FDA watchdog. the other thing is Lambert and the many other high profile investors wanting their cut, eventually, which asx yet to determine on timeline of escrowed shares, and not to mention high market cap
vs revenue.
I have questions, that's all I'm saying...glass half full v glass half empty?
